| Literature DB >> 28105273 |
Nicholas D Measom1, Kenneth D Down2, David J Hirst2, Craig Jamieson3, Eric S Manas4, Vipulkumar K Patel2, Don O Somers2.
Abstract
We describe the incorporation of a bicyclo[1.1.1]pentane moiety within two known LpPLA2 inhibitors to act as bioisosteric phenyl replacements. An efficient synthesis to the target compounds was enabled with a dichlorocarbene insertion into a bicyclo[1.1.0]butane system being the key transformation. Potency, physicochemical, and X-ray crystallographic data were obtained to compare the known inhibitors to their bioisosteric counterparts, which showed the isostere was well tolerated and positively impacted on the physicochemical profile.Entities:
Keywords: LpPLA2; bicyclo[1.1.1]pentane; bioisostere; cardiovascular disease; darapladib; physicochemical
Year: 2016 PMID: 28105273 PMCID: PMC5238484 DOI: 10.1021/acsmedchemlett.6b00281
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345